OpenURL Connection Search

Select item for more details and to access through your institution.

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
Published in:
Scientific Reports, 2015, p. 16331, doi. 10.1038/srep16331
By:
- Ganzinelli, Monica;
- Chiara Garassino, Marina;
- Cristina Locatelli, Maria;
- Bertolini, Alessandro;
- Valmadre, Giuseppe;
- Pavese, Ida;
- Calcagno, Anna;
- Giuseppa Sarobba, Maria;
- Rulli, Eliana;
- Caiola, Elisa;
- Broggini, Massimo;
- Copreni, Elena;
- Marabese, Mirko;
- Piva, Sheila;
- Longo, Flavia;
- Labianca, Roberto;
- Bareggi, Claudia;
- Agnese Fabbri, Maria;
- Martelli, Olga;
- Fagnani, Daniele
Publication type:
Article
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
Published in:
PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141763
By:
- Cossu-Rocca, Paolo;
- Orrù, Sandra;
- Muroni, Maria Rosaria;
- Sanges, Francesca;
- Sotgiu, Giovanni;
- Ena, Sara;
- Pira, Giovanna;
- Murgia, Luciano;
- Manca, Alessandra;
- Uras, Maria Gabriela;
- Sarobba, Maria Giuseppina;
- Urru, Silvana;
- De Miglio, Maria Rosaria
Publication type:
Article
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
Published in:
Breast Cancer Research & Treatment, 2006, v. 98, n. 3, p. 241, doi. 10.1007/s10549-005-9155-y
By:
- Marco Tampellini;
- Alfredo Berruti;
- Raffaella Bitossi;
- Gabriella Gorzegno;
- Irene Alabiso;
- Alberto Bottini;
- Antonio Farris;
- Michela Donadio;
- Maria Sarobba;
- Enrica Manzin;
- Antonio Durando;
- Enza Defabiani;
- Andrea De Matteis;
- Mara Ardine;
- Federico Castiglione;
- Saverio Danese;
- Elena Bertone;
- Oscar Alabiso;
- Marco Massobrio;
- Luigi Dogliotti
Publication type:
Article
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.
Published in:
Journal of Cellular Physiology, 2017, v. 232, n. 6, p. 1571, doi. 10.1002/jcp.25685
By:
- Gamucci, Teresa;
- Mentuccia, Lucia;
- Natoli, Clara;
- Sperduti, Isabella;
- Cassano, Alessandra;
- Michelotti, Andrea;
- Di Lauro, Luigi;
- Sergi, Domenico;
- Fabi, Alessandra;
- Sarobba, Maria G.;
- Marchetti, Paolo;
- Barba, Maddalena;
- Magnolfi, Emanuela;
- Maugeri‐Saccà, Marcello;
- Rossi, Ernesto;
- Sini, Valentina;
- Grassadonia, Antonino;
- Pellegrini, Domenica;
- Astone, Antonino;
- Nisticò, Cecilia
Publication type:
Article
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study.
Published in:
Targeted Oncology, 2022, v. 17, n. 6, p. 615, doi. 10.1007/s11523-022-00913-x
By:
- De Laurentiis, Michelino;
- Caputo, Roberta;
- Mazza, Manuelita;
- Mansutti, Mauro;
- Masetti, Riccardo;
- Ballatore, Zelmira;
- Torrisi, Rosalba;
- Michelotti, Andrea;
- Zambelli, Alberto;
- Ferro, Antonella;
- Generali, Daniele;
- Vici, Patrizia;
- Coltelli, Luigi;
- Fabi, Alessandra;
- Marchetti, Paolo;
- Ballestrero, Alberto;
- Spazzapan, Simon;
- Frassoldati, Antonio;
- Sarobba, Maria Giuseppina;
- Grasso, Donatella
Publication type:
Article

Found: 5

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).

Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study.